Alcon Canada Inc. et al. v. Apotex Inc. et al., (2014) 461 F.T.R. 259 (FC)

This document cites

• AbbVie Corp. v. Janssen Inc., [2014] F.T.R. Uned. 23 (FC)
• Sanofi-Synthelabo Canada Inc. et al. v. Apotex Inc. et al., (2008) 381 N.R. 125 (SCC)
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 432 N.R. 292 (FCA)
• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 440 N.R. 269 (FCA)
• Fournier Pharma Inc. et al. v. Canada (Minister of Health) et al., (2012) 413 F.T.R. 277 (FC)



See all quotations

• Allergan Inc. et al. v. Canada (Minister of Health) et al., (2012) 414 F.T.R. 56 (FC)
• Pfizer Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2012) 430 N.R. 326 (FCA)
• Young v. Dollar Financial Group Inc. et al., (2014) 471 N.R. 390 (Motion)
• Ruddell v. BC Rail Ltd., (2007) 381 N.R. 399 (Motion)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., (2008) 323 F.T.R. 56 (FC)
• Eli Lilly Canada Inc. v. Apotex Inc. et al., 2009 FCA 97
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., (2007) 366 N.R. 347 (FCA)
• Rothmans, Benson & Hedges Inc. et al. v. Imperial Tobacco Ltd., (1993) 152 N.R. 292 (FCA)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2009 FCA 94
• Biovail Corp. et al. v. Canada (Minister of Health) et al., (2010) 361 F.T.R. 158 (FC)
• Apotex Inc. v. Sanofi-Aventis, (2013) 447 N.R. 313 (FCA)
• Beloit Canada Ltd. v. Valmet Oy, (1986) 64 N.R. 287 (FCA)
• Monsanto Co. v. Commissioner of Patents, (1979) 28 N.R. 181 (SCC)
• Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2013) 433 F.T.R. 211 (FC)
• Pfizer Can. Inc. v. Novopharm, 2005 FCA 270
• Aventis Pharma Inc. v. Apotex Inc. et al., 2006 FCA 64
• GlaxoSmithKline Inc. et al. v. Pharmascience Inc. et al., (2011) 385 F.T.R. 157 (FC)
• Pfizer Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., (2014) 446 F.T.R. 274 (FC)
• Shire Biochem Inc. et al. v. Canada (Minister of Health) et al., (2008) 328 F.T.R. 123 (FC)
• Bayer Inc. et al. v. Cobalt Pharmaceuticals Co. et al., (2013) 441 F.T.R. 72 (FC)
• Pfizer Canada Inc. et al. v. Pharmascience Inc. et al., (2013) 427 F.T.R. 6 (FC)
• Pfizer Canada Inc. et al. v. Apotex Inc. et al., 2007 FC 26
• AstraZeneca Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 1023
• Pfizer Canada Inc. et al. v. Mylan Pharmaceuticals ULC et al., 2011 FC 547
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., (2007) 361 N.R. 308 (FCA)
• Pfizer Canada Inc. et al. v. Canada (Minister of Health) et al., 2011 FCA 236
• Apotex Inc. and Novopharm Ltd. v. Wellcome Foundation Ltd., (2002) 296 N.R. 130 (SCC)
• AstraZeneca AB et al. v. Apotex Inc. et al., (2005) 335 N.R. 1 (FCA)
• Abbott Laboratories et al. v. Canada (Minister of Health) et al., 2008 FC 1359
• Consolboard Inc. v. MacMillan Bloedel (Saskatchewan) Ltd., (1981) 35 N.R. 390 (SCC)